Autor/in Barlesi, F 1 Bennouna, J 1 Feurer, M 1 Germonpre, P 1 Goekkurt, E 1 Gridelli, C 1 Milanowski, J 1 Szczesna, A Vansteenkiste, J Verhoeven, D 1 Waller, C F alle zeigenListe einklappen
Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO) Vansteenkiste, J Barlesi, F Waller, C F Bennouna, J Gridelli, C Goekkurt, E Verhoeven, D 2015 - Forschungsinformationssystem des UKE
